The Institute for Protein Innovation (IPI) is a grand experiment in innovative science. The IPI was founded in 2017 to tackle scientific challenges that could not be addressed by industry or academia. Central to the IPI mission is to produce open source protein science reagents, tools and technologies, and to disseminate and distribute them the global scientific community. The IPI takes on Institutional Initiatives, which are massive scientific projects that require a scale that is unattainable by a traditional academic organization, and for which the financial incentives make it impossible for the private sector to perform. The IPI's first is the Antibody Initiative, which aims to create, gather, maintain, and distribute a repository of high-quality, monoclonal, open-source antibodies that are highly validated both internally and by the scientific community for the entire human proteome, focusing first on extracellular and secreted proteins.
Company HQ State:
Company HQ Country:
Main Therapeutic Focus:
Lead Product in Development:
Development Phase of Primary Product:
Number Of Unlicensed Products (For Which You Are Seeking Partners):